Abstract: Monolithic microwave integrated circuits are provided that include a substrate, a transmit/receive selection device that is formed on the substrate, a high power amplifier formed on the substrate and coupled to a first RF port of the transmit/receive selection device, a low noise amplifier formed on the substrate and coupled to a second RF port of the transmit/receive selection device and a protection circuit that is coupled to a first control port of the transmit/receive selection device.

Abstract: Monolithic microwave integrated circuits are provided that include a substrate, a transmit/receive selection device that is formed on the substrate, a high power amplifier formed on the substrate and coupled to a first RF port of the transmit/receive selection device, a low noise amplifier formed on the substrate and coupled to a second RF port of the transmit/receive selection device and a protection circuit that is coupled to a first control port of the transmit/receive selection device.

Abstract: A drug delivery device with removable pods is described and related pods methods and systems. The drug delivery device comprises a plurality of receptacles, each receptacle configured to accept a corresponding drug pod, wherein each receptacle comprises: a recess configured to accept a protrusion in the corresponding drug pod, or a protrusion configured to insert in a recess in the corresponding drug pod. The corresponding drug pod comprises a shell, made of an impermeable polymer, having a first base comprising an opening configured to allow delivery of a drug, a second base, a lateral surface, a protrusion attached to, and extending away from, the lateral surface, or a recess in the lateral surface.

Abstract: The present invention provides for a drug delivery device. The device can comprise at least one core with a first active pharmaceutical ingredient (API), coated with a first layer that is permeable or semi-permeable to the API, coated with a second layer that is impermeable to the API and having a delivery window to allow passage of the API through the device and into body fluids or tissues. The device can also have a wicking material to modify the rate of transport of the API into the body fluid or tissues.

Abstract: An unchamfered piston ring that is pre-treated by grit blasting to a defined roughness, followed by PVD coating with a metal nitride to a thickness of at least 10 ?m, leaving peaks and valleys in the coated piston ring. The coated piston ring is then lapped to remove the peaks without penetrating the coating, so that valleys and plateaus remain in the coated surface. The resulting piston ring exhibits superior coating retention due to the increased surface area created by the grit blasting, and yet also superior performance, as the cavities remaining increase the porosity of the coating and thus enhance the lubrication of the ring.

Abstract: Monolithic microwave integrated circuits are provided that include a substrate, a transmit/receive selection device that is formed on the substrate, a high power amplifier formed on the substrate and coupled to a first RF port of the transmit/receive selection device, a low noise amplifier formed on the substrate and coupled to a second RF port of the transmit/receive selection device and a protection circuit that is coupled to a first control port of the transmit/receive selection device.

Abstract: A method of forming a piston ring includes providing a base portion formed of a metallic material, the base portion having a first surface, and a second surface that is opposite the first surface, the base portion configured to interface with a piston ring groove. The method includes grinding the first surface to form a reference surface, applying a chromium layer to the second surface, and grinding the chromium layer to reduce a surface roughness of the chromium layer.

Abstract: A piston ring that is pre-treated by grit blasting to a defined roughness, followed by PVD coating with a metal nitride to a thickness of at least 10 ?m, leaving peaks and valleys in the coated piston ring. The coated piston ring is then lapped to remove the peaks without penetrating the coating, so that valleys and plateaus remain in the coated surface. The resulting piston ring exhibits superior coating retention due to the increased surface area created by the grit blasting, and yet also superior performance, as the cavities remaining increase the porosity of the coating and thus enhance the lubrication of the ring.

Abstract: A piston ring that is pre-treated by grit blasting to a defined roughness, followed by PVD coating with a metal nitride to a thickness of at least 10 ?m, leaving peaks and valleys in the coated piston ring. The coated piston ring is then lapped to remove the peaks without penetrating the coating, so that valleys and plateaus remain in the coated surface. The resulting piston ring exhibits superior coating retention due to the increased surface area created by the grit blasting, and yet also superior performance, as the cavities remaining increase the porosity of the coating and thus enhance the lubrication of the ring.

Abstract: Exemplary oil control rings and methods are disclosed. An oil control ring may include an upper lamella having a first outer radial surface and a lower lamella having a second outer radial surface. An expander ring is in communication with the upper lamella and the lower lamella and generates an expander radial outward force on the lamellas. At least one of the first outer radial surface and the second outer radial surface is comprised of a first contact section and a first tapered section. The first tapered section is configured to generate a first radially inward force greater than or equal to the expander radial outward force when moved in a first direction and a second radially inward force less than the expander radial outward force when moved in a second direction.

Abstract: The present invention provides for a drug delivery device. The device can comprise at least one core with a first active pharmaceutical ingredient (API), coated with a first layer that is permeable or semi-permeable to the API, coated with a second layer that is impermeable to the API, and having a delivery window to allow passage of the API through the device and into body fluids or tissues. The device can also have a wicking material to modify the rate of transport of the API into the body fluid or tissues.

Abstract: A piston ring that is pre-treated by grit blasting to a defined roughness, followed by PVD coating with a metal nitride to a thickness of at least 10 ?m, leaving peaks and valleys in the coated piston ring. The coated piston ring is then lapped to remove the peaks without penetrating the coating, so that valleys and plateaus remain in the coated surface. The resulting piston ring exhibits superior coating retention due to the increased surface area created by the grit blasting, and yet also superior performance, as the cavities remaining increase the porosity of the coating and thus enhance the lubrication of the ring.

Abstract: Exemplary pistons and methods are disclosed. A method may include depositing a scuff and seizure resistant material via a thermal spray method on the surface of a piston pin bore used in internal combustion engines. Exemplary pistons may have a crown and a skirt. The piston crown may define a combustion bowl and a ring land extending circumferentially around the combustion bowl, the skirt supporting the crown, the skirt including a pair of pin bosses, the pin bosses each defining a pin bore configured to receive a piston pin, each pin bore defining a pin bore surface extending circumferentially about the piston pin bore, the bore surface formed of a first material. The method may further include applying a coating comprising at least a second material different from the first material to the pin bore surfaces using a thermal spray process.

Abstract: Described herein are injectable corticosteroid-loaded microparticles, pharmaceutical composition thereof and methods for reducing inflammation or pain in a body compartment such as a joint, an epidural space, a vitreous body of an eye, a surgically created space, or a space adjacent to an implant.

Abstract: Described herein are injectable corticosteroid-loaded microparticles, pharmaceutical composition thereof and methods for reducing inflammation or pain in a body compartment such as a joint, an epidural space, a vitreous body of an eye, a surgically created space, or a space adjacent to an implant.

Abstract: The present invention provides for a drug delivery device. The device can comprise at least one core with a first active pharmaceutical ingredient (API), coated with a first layer that is permeable or semi-permeable to the API, coated with a second layer that is impermeable to the API, and having a delivery window to allow passage of the API through the device and into body fluids or tissues. The device can also have a wicking material to modify the rate of transport of the API into the body fluid or tissues.

Abstract: Described herein are injectable corticosteroid-loaded microparticles, pharmaceutical composition thereof and methods for reducing inflammation or pain in a body compartment such as a joint, an epidural space, a vitreous body of an eye, a surgically created space, or a space adjacent to an implant.

Abstract: Described herein are injectable corticosteroid-loaded microparticles, pharmaceutical composition thereof and methods for reducing inflammation or pain in a body compartment such as a joint, an epidural space, a vitreous body of an eye, a surgically created space, or a space adjacent to an implant.

Abstract: A method of forming a piston ring includes providing a base portion formed of a metallic material, the base portion having a first surface, and a second surface that is opposite the first surface, the base portion configured to interface with a piston ring groove. The method includes grinding the first surface to form a reference surface, applying a chromium layer to the second surface, and grinding the chromium layer to reduce a surface roughness of the chromium layer.

Abstract: Coated microparticles for sustained-release of an active pharmaceutical ingredient after parenteral administration, and methods of producing such coated microparticles, are provided. The coated microparticles comprise core particles of an active pharmaceutical ingredient and a first polymeric coating on the core particles. The first polymeric coating is permeable to the active pharmaceutical ingredient forms a saturated solution within the coated microparticle, resulting in pseudo-zero-sustained release period. A second polymeric coating can be employed to add mechanical support or as a rate-controlling element.